Exploring MAO inhibitory activity of 5-hydroxy regioisomers of hispidol’s analogs leads to identification of novel highly selective MAO-B open-conformation inhibitors | Synapse
March 3, 2026
Exploring MAO inhibitory activity of 5-hydroxy regioisomers of hispidol’s analogs leads to identification of novel highly selective MAO-B open-conformation inhibitors
Key Points
Discovery of novel selective inhibitors targeting MAO-B activity is significant for therapeutic applications.
The research revealed that specific regioisomers of hispidol's analogs exhibit potent MAO-B inhibition.
Approach based on the exploration of the MAO inhibitory activity of various analogs provides crucial insights.
Highlights the importance of structural configuration in developing effective MAO-B inhibitors for treatment.